INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2024

Taurine supplementation significantly reduced blood pressure, fasting glucose, and triglycerides in a meta-analysis of randomized controlled trials.

A meta-analysis evaluated 25 randomized controlled trials with 1,024 participants receiving 0.5 to 6 g/day of taurine for 5 to 365 days. Taurine supplementation led to statistically significant reductions in SBP (WMD = -3.999 mmHg, p = 0.017), DBP (WMD = -1.509 mmHg, p = 0.002), fasting blood glucose (WMD = -5.882 mg/dL, p = 0.018), and triglycerides (WMD = -18.315 mg/dL, p < 0.001), but not HDL-C (p = 0.155). Meta-regression revealed dose-dependent reductions in DBP (-0.0108 mmHg per g, p = 0.0297) and FBG (-0.0445 mg/dL per g, p = 0.0273). No significant adverse effects were observed compared to control groups.

Study type
Systematic review and meta-analysis of RCTs
Who was studied
1,024 participants across 25 randomized controlled trials
What was measured
Metabolic syndrome parameters including SBP, DBP, fasting blood glucose, triglycerides, and HDL-C

THE PAPER

Taurine reduces the risk for metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials.

Tzang CC, Chi LY, Lin LH, Lin TY, Chang KV, Wu WT, Özçakar L. Nutr Diabetes, 2024.

PubMed 38755142 ↗DOI 10.1038/s41366-020-00731-z ↗

Heart & arteriesDiabetes & blood sugarBlood pressure

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.